PA GOODDOCTOR (01833.HK) -0.120 (-1.289%) Short selling $8.92M; Ratio 11.037% 's 1Q26 results reflected operations advancing toward its full-year target, Morgan Stanley said in a research report. 1Q26 revenue added 9.1% YoY to RMB1.16 billion; net profit swelled 138.4% YoY to RMB79.1 million; adjusted net profit grew 45.8% YoY to RMB84.4 million. The broker noted that the modest revenue growth likely reflects change of service offering models and accounting method, while profit growth better demonstrates the real economics.Related News CICC Initiates PA GOODDOCTOR (01833.HK) with Outperform Rating, TP HKD14.2As of the end of 1Q26, the number of AI doctor users numbered 5.6 million, with about 95% AI assisted accuracy for complex disease plans from the MDT platform.The broker assigned PA GOODDOCTOR a TP of HKD16.8 and maintained an Equalweight rating. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)
AASTOCKS Financial News